lactagen  ritter pharmaceuticals ritter pharmaceuticals  therapeutic treatments for gastrointestinal diseases careerscontact connect with us home about us history leadership overview leadership team medical advisory board board of directors lactose intolerance overview health consequences standard of care market opportunity patient resources microbiome modulation investors overview events  presentations corporate governance sec filings  stock info investor faqs contact us news press releases  news blog contact us contact us careers lactagen rpg product pipeline  print this page lactagen® after experiencing great success with lactagen® ritter pharmaceuticals is pursuing fda approval in order to develop the first prescription treatment for lactose intolerance unfortunately lactagen® is no longer for sale lactagen® has been successful in helping thousands of lactose intolerant sufferers and we hope to help millions in the future unfortunately based on the regulatory restrictions in the us europe and around the world going through regulatory clinical trials is the most prudent approach to ensure worldwide application and availability of our product we are working as fast as possible to bring this treatment to the market about ritter pharmaceuticals inc ritter pharmaceuticals inc develops novel therapeutic products which modulate the human gut microbiome and has the potential to treat inflammatory gastrointestinal and metabolic diseases our microbiome modulators provide specialized nutrition that selectively increases the growth of beneficial bacteria in the colonic ecosystem and creates significant improvement in the health of individuals that suffer from these diseases about rpg a treatment for lactose intolerance rpg has the potential to become the first fdaapproved drug for the treatment of lactose intolerance a debilitating disease that affects over  billion people worldwide the product is understood to stimulate the growth of lactosemetabolizing bacteria in the colon which reduces lactosederived gas production and thereby mitigates the symptoms of lactose intolerance in the process rpgfor the treatment of lactose intolerance is currently in late stage  clinical trials you may read more about rpg’s recently published clinical data at httpwwwnutritionjcomcontentpdfpdf to join our mailing list and keep up to date with our research and progress please email us at inforitterpharmacom faq’s when will this product be available we are sorry that we cannot provide a timetable at this time you may follow our development and progress by visiting our website at wwwritterpharmacom or by going to wwwclinicaltrialsgov can i participate in a clinical study clinical trials are not in enrollment at this time you can learn more about participating in clinical trials at wwwclinicaltrialsgov for more information home    about us    investors    therapies    platform    leadership    lactose intolerance    news     contact us    privacy policy    terms  conditions    site map  copyright  ritter pharmaceuticals all rights reserved featuring recent posts wordpress widget development by yd ritter pharmaceuticals lactose intolerance colonic adaptation gastrointestinal diseases ritter pharmaceuticals  therapeutic treatments for gastrointestinal diseases careerscontact connect with us home about us history leadership overview leadership team medical advisory board board of directors lactose intolerance overview health consequences standard of care market opportunity patient resources microbiome modulation investors overview events  presentations corporate governance sec filings  stock info investor faqs contact us news press releases  news blog contact us contact us careers lactagen rpg product pipeline about ritter pharmaceuticals ritter pharmaceuticals inc is a specialty pharmaceutical company developing therapeutics based upon colonic adaptation to treat gastrointestinal diseases with an initial focus on lactose intolerance colonic adaptation improves colon function by selectively increasing the growth of beneficial bacteria in the colonic ecosystem digestive tract ritter pharmaceuticals inc is rapidly establishing itself as the world’s leader in lactose intolerance research based upon its scientific team and their cutting edge research in this field rpg ritter’s lead product has been studied in a phase  trial and is a firstinclass compound rpg has the potential to become the first fdaapproved drug for the treatment of lactose intolerance a debilitating disease which affects over  billion people worldwide ritter’s medical advisory board represents the world’s experts in lactose intolerance worldwide more than  billion people suffer from lactose intolerance read more about lactose intolerance a breakthrough treatment aiming to eradicate symptoms of lactose intolerance potential to become the first fdaapproved product to treat lactose intolerance studied in phase  trial ritter pharmaceuticals reports first quarter  financial results and provides business updateslos angeles may   – ritter pharmaceuticals inc nasdaq rttr “ritter pharmaceuticals” or the “company”… »ritter pharmaceuticals announces issuance of new patents for its lactose intolerance treatment rpg and provides an updatelos angeles may   – ritter pharmaceuticals inc nasdaq rttr “ritter pharmaceuticals” or the “company”… » home    about us    investors    therapies    platform    leadership    lactose intolerance    news     contact us    privacy policy    terms  conditions    site map  copyright  ritter pharmaceuticals all rights reserved featuring recent posts wordpress widget development by yd ritter pharmaceuticals lactose intolerance colonic adaptation gastrointestinal diseases ritter pharmaceuticals  therapeutic treatments for gastrointestinal diseases careerscontact connect with us home about us history leadership overview leadership team medical advisory board board of directors lactose intolerance overview health consequences standard of care market opportunity patient resources microbiome modulation investors overview events  presentations corporate governance sec filings  stock info investor faqs contact us news press releases  news blog contact us contact us careers lactagen rpg product pipeline about ritter pharmaceuticals ritter pharmaceuticals inc is a specialty pharmaceutical company developing therapeutics based upon colonic adaptation to treat gastrointestinal diseases with an initial focus on lactose intolerance colonic adaptation improves colon function by selectively increasing the growth of beneficial bacteria in the colonic ecosystem digestive tract ritter pharmaceuticals inc is rapidly establishing itself as the world’s leader in lactose intolerance research based upon its scientific team and their cutting edge research in this field rpg ritter’s lead product has been studied in a phase  trial and is a firstinclass compound rpg has the potential to become the first fdaapproved drug for the treatment of lactose intolerance a debilitating disease which affects over  billion people worldwide ritter’s medical advisory board represents the world’s experts in lactose intolerance worldwide more than  billion people suffer from lactose intolerance read more about lactose intolerance a breakthrough treatment aiming to eradicate symptoms of lactose intolerance potential to become the first fdaapproved product to treat lactose intolerance studied in phase  trial ritter pharmaceuticals reports first quarter  financial results and provides business updateslos angeles may   – ritter pharmaceuticals inc nasdaq rttr “ritter pharmaceuticals” or the “company”… »ritter pharmaceuticals announces issuance of new patents for its lactose intolerance treatment rpg and provides an updatelos angeles may   – ritter pharmaceuticals inc nasdaq rttr “ritter pharmaceuticals” or the “company”… » home    about us    investors    therapies    platform    leadership    lactose intolerance    news     contact us    privacy policy    terms  conditions    site map  copyright  ritter pharmaceuticals all rights reserved featuring recent posts wordpress widget development by yd ritter pharmaceuticals lactose intolerance experts pharma biotech experience  ritter pharmaceuticals ritter pharmaceuticals  therapeutic treatments for gastrointestinal diseases careerscontact connect with us home about us history leadership overview leadership team medical advisory board board of directors lactose intolerance overview health consequences standard of care market opportunity patient resources microbiome modulation investors overview events  presentations corporate governance sec filings  stock info investor faqs contact us news press releases  news blog contact us contact us careers lactagen rpg product pipeline  print this page leadership team ritter pharma has recruited and assembled an outstanding team of talented and experienced individuals with extensive big pharma  biotech experience michael d step chief executive officer prior to joining ritter mr step was the senior vice president of corporate development for santarus inc now a wholly owned subsidiary of salix pharmaceuticals inc mr step served in this role for nine years up until the  sale of santarus to salix mr step was responsible for leading all licensing and ma activities at santarus and was a member of its executive team prior to his tenure at santarus mr step held various commercial and business development roles at amylin pharmaceuticals for  years culminating in the role of vice president of corporate development and was responsible for leading amylin’s license of byetta to eli lilly before joining amylin mr step was sr director of business development at dura pharmaceuticals and served in licensing management and sales roles at hoffmannla roche and syntex labs mr step has an mba degree in marketing and finance from the usc marshall school of business and an undergraduate degree from vanderbilt university andrew j ritter cofounder  president mr ritter cofounded ritter pharmaceuticals inc upon his own personal affliction with lactose intolerance and spearheaded a global team of crossfunctional clinical manufacturing and regulatory experts to design and develop its first novel therapeutic called rpg this product has been successfully tested in a phase a trial and has the potential to become the first fdaapproved drug for the treatment of lactose intolerance the company was originally launched out of ritter naturals sciences a directtoconsumer healthcare marketing company founded by mr ritter in  which developed and commercialized digestive healthcare products lactagen® health essentials™ and better digestion™ mr ritter holds six patents and over fifteen additional international patents are pending in addition he has copublished articles in the following journals nutrition journal gastroenterology and food technology he has also given presentations at major healthcare and medical conferences such as digestive disease week among others since  mr ritter has also acted as managing partner of stonehenge partners a private investment fund which provides working capital and executive leadership to a variety of businesses and industries including real estate technology biotechnology entertainment and service businesses in addition he is a guest lecturer of entrepreneurship at various graduate and undergraduate academic institutions throughout los angeles including university of southern california marshall school of business university of california at los angeles anderson school of business and pepperdine university graziadio school of business and management mr ritter has been an active leader in his community including being appointed as a los angeles city commissioner to the commission for children youth and their families from  the youngest appointed commissioner in los angeles history mr ritter holds a bachelor of arts degree in political science and a minor in business from the university of southern california and was a member of the  pac champion baseball team in addition mr ritter received his mba from the wharton school university of pennsylvania ira e ritter cofounder  chief strategic officer mr ritter has extensive experience creating building and managing diverse business enterprises his success has been his ability to take ideas and grow major businesses he currently serves as chairman of ritter pharmaceuticals in addition he provides corporate management strategic planning and financial consulting for a wide range of market segments in the health and beauty sector mr ritter was president and vicechairman of quality king inc the nation’s largest wholesale distributor for health care products with  billion in annual revenues ranked the th largest privately held company forbes top  list simultaneously he worked as president and chairman of rockwood a business he developed that produced private label hba products for major national retailers including gnc and kmart in the entertainment sector he served as chairman of ontv a division of oak industries nyse company where he managed the television division initiating exclusive broadcasts of los angeles chicago and new york professional baseball basketball and hockey games during  he produced the first televised home shopping program and directed development of the largest “payperview” channel system for its time in the personal services market mr ritter grew a peopletopeople business elite personal search and lifemates personal matchmaking service in the us and canada in the finance field mr ritter served on the board of directors for the martin lawrence art galleries nyse company during his  years as a publisher he produced monthly national consumer magazines including playgirl and released books that included it’s ok to say no childrens series and patti regan davis’ homefront mr ritter also has a long history of public service that includes appointments by three governors to several state of california commissions including eight years served as commissioner on the california prison industry authority in  mr ritter was honored with the city of hope’s man of the year award ellen mochizuki vice president finance ms mochizuki has over  years of experience in financial accounting prior to joining ritter pharmaceuticals inc ms mochizuki consulted with various biopharmaceutical clients with respect to their initial public offerings and related financial statements as well as assisting with a stock merger for a publicly traded midsize banking client from  to  ms mochizuki served as director of accounting benefits for northrop grumman corporation ngc where she was responsible for the overall accounting and accounting operations of its benefit assets of over  billion including the filing of over twenty external financial statements annually from  to  ms mochizuki was a consultant for ngc from  to  ms mochizuki was senior vice president at indymacbank where she oversaw human resources operations ms mochizuki started her career as an auditor with pricewaterousecoopers llp in addition ms mochizuki is an adjunct faculty at pasadena city college teaching accounting present ms mochizuki is licensed in the state of california as a certified public accountant though is currently on inactive status leadership board of directors leadership team medical advisory board overview home    about us    investors    therapies    platform    leadership    lactose intolerance    news     contact us    privacy policy    terms  conditions    site map  copyright  ritter pharmaceuticals all rights reserved featuring recent posts wordpress widget development by yd ritter pharmaceuticals inc private company information  bloomberg july    am et pharmaceuticals company overview of ritter pharmaceuticals inc snapshot people company overview ritter pharmaceuticals inc a specialty pharmaceutical company develops novel therapeutic products that modulate the human gut microbiome to treat gastrointestinal diseases its lead product candidate is rpg a novel microbiome modulator which has completed phase b clinical trial for the reduction of symptoms associated with lactose intolerance the company’s product rpg is designed to stimulate the growth of lactosemetabolizing bacteria in the colon thereby adapting the gut microbiome to assist in digesting the lactose that reaches the large intestine it is also exploring the functionality and discovering the therapeutic potential gut microbiome changes may have on treating ritter pharmaceuticals inc a specialty pharmaceutical company develops novel therapeutic products that modulate the human gut microbiome to treat gastrointestinal diseases its lead product candidate is rpg a novel microbiome modulator which has completed phase b clinical trial for the reduction of symptoms associated with lactose intolerance the company’s product rpg is designed to stimulate the growth of lactosemetabolizing bacteria in the colon thereby adapting the gut microbiome to assist in digesting the lactose that reaches the large intestine it is also exploring the functionality and discovering the therapeutic potential gut microbiome changes may have on treatingpreventing various conditions including gastrointestinal diseases immunooncology metabolic and liver disease the company was formerly known as ritter natural sciences llc and changed its name to ritter pharmaceuticals inc in september  ritter pharmaceuticals inc was founded in  and is headquartered in los angeles california detailed description  century park eastsuite los angeles ca united statesfounded in  employees phone  fax  wwwritterpharmaceuticalscom key executives for ritter pharmaceuticals inc mr michael d step ceo  director age  total annual compensation k mr andrew j ritter cofounder president corporate secretary  director age  total annual compensation k mr ira e ritter cofounder executive chairman  chief strategic officer age  total annual compensation k compensation as of fiscal year  ritter pharmaceuticals inc key developments ritter pharmaceuticals receives noncompliance notice from nasdaq jun   on june   ritter pharmaceuticals inc received a letter notice from the nasdaq stock market nasdaq notifying the company that because the closing bid price for its common stock has been below  per share for  consecutive business days it no longer complies with the minimum bid price requirement for continued listing on the nasdaq capital market nasdaq listing rule a requires listed securities to maintain a minimum bid price of  per share the “minimum bid price requirement” and listing rule ca provides that a failure to meet the minimum bid price requirement exists if the deficiency continues for a period of  consecutive business days the notice has no immediate effect on the listing of the common stock on the nasdaq capital market pursuant to nasdaq marketplace rule ca the company has been provided an initial compliance period of  calendar days or until december   to regain compliance with the minimum bid price requirement during the compliance period the company’s shares of common stock will continue to be listed and traded on the nasdaq capital market to regain compliance the closing bid price of the company’s common stock must meet or exceed  per share for a minimum of  consecutive business days during the  calendar day grace period in the event the company is not in compliance with the minimum bid price requirement by december   the company may be afforded a second  calendar day grace period to qualify the company would be required to meet the continued listing requirements for market value of publicly held shares and all other initial listing standards for the nasdaq capital market with the exception of the minimum bid price requirement in addition the company would be required to provide written notice of its intention to cure the minimum bid price deficiency during this second  day compliance period by effecting a reverse stock split if necessary the company intends to actively monitor the bid price for its common stock between now and december   and will consider available options to regain compliance with the minimum bid price requirement ritter pharmaceuticals inc announces unaudited earnings results for the first quarter ended march   may   ritter pharmaceuticals inc announced unaudited earnings results for the first quarter ended march   for the period the companys operating loss was  compared to  a year ago the company reported a net loss attributable to common stockholders of approximately  million compared to a net loss of approximately  million for the first quarter of  basic and diluted net loss per share was  for the three months ended march   compared to basic and diluted net loss per share of  for the same period in  ritter pharmaceuticals inc annual general meeting jun   apr   ritter pharmaceuticals inc annual general meeting jun   at  pacific standard time location  avenue of the stars suite  los angeles ca  united states agenda to elect as directors the eight nominees to ratify the appointment of mayer hoffman mccann pc as independent registered public accounting firm for the fiscal year ending december   to approve the amendment of the companys  equity incentive plan in substantially the form of annex a to this proxy statement to increase the number of shares that may be issued pursuant to awards thereunder by  shares to an aggregate of i  shares plus ii any shares that were available for grant under the  stock plan and the  stock plan on the effective date of the  equity incentive plan or were subject to awards under the prior plans that after the effective date of the  equity incentive plan were or are forfeited or lapse unexercised or were or are settled in cash and are not issued under the prior plans similar private companies by industry company name region st order pharmaceuticals inc united states st century animal health united states  buds organics llc united states p therapeutics llc united states ° pharmaceuticals llc united states recent private companies transactions typedate target no transactions available in the past  months request profile update   the information and data displayed in this profile are created and managed by sp global market intelligence a division of sp global bloombergcom does not create or control the content for inquiries please contact sp global market intelligence directly by clicking here stock quotes market data is delayed at least  minutes company lookup most searched private companies company name geographic region lawyers committee for civil rights under law united states nyc inc united states the advertising council inc united states bertelsmann ag europe rush university united states sponsored financial commentaries sponsored links browse companies a b c d e f g h i j k l m n o p q r s t u v w x y z              request profile update only a company representative may request an update for the company profile documentation will be required to contact ritter pharmaceuticals inc please visit wwwritterpharmaceuticalscom company data is provided by sp global market intelligence please use this form to report any data issues information missing  please enter your information in the following fields company name your name your email address your phone number type of data overview executives key developments similar companies transactions update needed all data changes require verification from public sources please include the correct value or values and a source where we can verify cancel submit your requested update has been submitted our data partners will research the update request and update the information on this page if necessary research and followup could take several weeks if you have questions you can contact them at bwwebmasterbusinessweekcom close ritter pharmaceuticals lactose intolerance drug development company  ritter pharmaceuticals ritter pharmaceuticals  therapeutic treatments for gastrointestinal diseases careerscontact connect with us home about us history leadership overview leadership team medical advisory board board of directors lactose intolerance overview health consequences standard of care market opportunity patient resources microbiome modulation investors overview events  presentations corporate governance sec filings  stock info investor faqs contact us news press releases  news blog contact us contact us careers lactagen rpg product pipeline  print this page about ritter pharmaceuticals inc ritter pharmaceuticals inc develops novel therapeutic products that modulate the human gut microbiome to treat gastrointestinal diseases we are advancing human gut health research by exploring the metabolic capacity of the gut microbiota and translating the functionality of gut modulation into applications intended to have a meaningful impact on a patient’s health ritter’s leadership team has extensive biotechnology expertise in discovering developing and commercializing therapeutic products we have attracted a scientific team comprised of innovative researchers who are world renowned in their knowledge and understanding of the hostmicrobiome combined our expertise is leading the way in the understanding of the host gut microbiome and the discovery in novel microbiome modulators our lead compound rpg is currently under development for the treatment of lactose intolerance rpg has the potential to become the first fdaapproved drug for the treatment of lactose intolerance a debilitating disease that affects over  billion people worldwide the product stimulates the growth of lactosemetabolizing bacteria in the colon which reduces lactosederived gas production and thereby mitigates the symptoms of lactose intolerance in the process home    about us    investors    therapies    platform    leadership    lactose intolerance    news     contact us    privacy policy    terms  conditions    site map  copyright  ritter pharmaceuticals all rights reserved featuring recent posts wordpress widget development by yd ritter pharmaceuticals colonic adaptation platform rpg post phase   ritter pharmaceuticals ritter pharmaceuticals  therapeutic treatments for gastrointestinal diseases careerscontact connect with us home about us history leadership overview leadership team medical advisory board board of directors lactose intolerance overview health consequences standard of care market opportunity patient resources microbiome modulation investors overview events  presentations corporate governance sec filings  stock info investor faqs contact us news press releases  news blog contact us contact us careers lactagen rpg product pipeline  print this page product pipeline our focus is on exploring and developing novel microbiome modulators that change and enhance the microbial populations in the gastrointestinal tract in order to improve the health of individuals suffering from a variety of gastrointestinal diseases microbiome modulators are dietary based gut microbiota management tools that improve gut health by fortifying and stimulating the growth of beneficial bacteria indigenous to the digestive tract our technology has expansive promise in the development of therapeutic treatments for a variety of conditions including orphan indications with unmet medical need therapies product pipeline rpg home    about us    investors    therapies    platform    leadership    lactose intolerance    news     contact us    privacy policy    terms  conditions    site map  copyright  ritter pharmaceuticals all rights reserved featuring recent posts wordpress widget development by yd ritter pharmaceuticals lactose intolerance colonic adaptation gastrointestinal diseases ritter pharmaceuticals  therapeutic treatments for gastrointestinal diseases careerscontact connect with us home about us history leadership overview leadership team medical advisory board board of directors lactose intolerance overview health consequences standard of care market opportunity patient resources microbiome modulation investors overview events  presentations corporate governance sec filings  stock info investor faqs contact us news press releases  news blog contact us contact us careers lactagen rpg product pipeline about ritter pharmaceuticals ritter pharmaceuticals inc is a specialty pharmaceutical company developing therapeutics based upon colonic adaptation to treat gastrointestinal diseases with an initial focus on lactose intolerance colonic adaptation improves colon function by selectively increasing the growth of beneficial bacteria in the colonic ecosystem digestive tract ritter pharmaceuticals inc is rapidly establishing itself as the world’s leader in lactose intolerance research based upon its scientific team and their cutting edge research in this field rpg ritter’s lead product has been studied in a phase  trial and is a firstinclass compound rpg has the potential to become the first fdaapproved drug for the treatment of lactose intolerance a debilitating disease which affects over  billion people worldwide ritter’s medical advisory board represents the world’s experts in lactose intolerance worldwide more than  billion people suffer from lactose intolerance read more about lactose intolerance a breakthrough treatment aiming to eradicate symptoms of lactose intolerance potential to become the first fdaapproved product to treat lactose intolerance studied in phase  trial ritter pharmaceuticals reports first quarter  financial results and provides business updateslos angeles may   – ritter pharmaceuticals inc nasdaq rttr “ritter pharmaceuticals” or the “company”… »ritter pharmaceuticals announces issuance of new patents for its lactose intolerance treatment rpg and provides an updatelos angeles may   – ritter pharmaceuticals inc nasdaq rttr “ritter pharmaceuticals” or the “company”… » home    about us    investors    therapies    platform    leadership    lactose intolerance    news     contact us    privacy policy    terms  conditions    site map  copyright  ritter pharmaceuticals all rights reserved featuring recent posts wordpress widget development by yd microsoft personalized ad preferences to opt out of personalized ads in this browser your browser history must allow firstparty and thirdparty cookies and you must have your browsing experience set to not delete browsing history on exit instructions for enabling cookies and configuring your browsing history may be available in your browsers settings privacy or help documentation sign in hold on… we’re sorry but this didn’t work you can’t turn off personalized ads right now because your browser is currently blocking thirdparty cookies we can help you fix this issue let’s get started depending on what browser you use open options or settings make sure that thirdparty cookies are not blocked anymore to find out how search your browser’s help revisit httpchoicemicrosoftcomoptout and then on the “personalized ads in this browser” tile click off ext about our ads to create a more customized online experience some of the ads you may receive on microsoft websites and apps are tailored to your previous activities searches and site visits youre in control and heres where you can make the advertising choice thats right for you ext where can i learn more about advertising on microsoft websites and apps microsoft partners with oath appnexus and other third party service providers to help present customized content and display advertisements on msn outlookcom and other websites and apps microsoft also delivers search ads to bing and our search syndication partners learn more about microsoft’s privacy practices here you can learn more about interestbased ads from oath and appnexus in their privacy statements oath and appnexus what choices do i have about interestbased advertising on this page you can opt out of receiving interest based advertising from microsoft you can also opt out of receiving interestbased advertising from all selfregulatory members including microsoft oath appnexus and other third party ad networks at the following sites in the us digital advertising alliance daa in europe european interactive digital advertising alliance edaa in canada ad choices digital advertising alliance of canada daac you can control interestbased advertising in windows apps by turning off the advertising id in windows settings more choices do you want personalized ads from other companies questions if you have a privacy question or a question for the chief privacy officer of microsoft please contact us by using our web form we will respond to questions within  days ext personalized ads in this browser off optout is currently unavailable please try again later control the personalized ads setting for this web browser learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off ext personalized ads wherever i use my microsoft account off sign in to change optout is currently unavailable please try again later control the personalized ads setting that applies when you are signed in on any computer or device with your microsoft account including windows windows phone xbox and other devices learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off if you choose “generic” ads and use a browser your choice applies to everyone when using that browser as long as you do not clear your cookies ext personalized ads in windows in your windows settings you can turn off personalized ads that appear in apps on this device you’ll still see ads but they won’t be personalized anymore if you have windows  access the charms by touching or moving your pointer to the right edge of the screen click or tap settings and then click or tap change pc settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have windows  click or tap the start button click or tap settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have a windows mobile device go to settings tap on privacy tap on advertising id and then turn off let apps use my advertising id for experiences across apps if you want to turn off personalized ads from microsoft wherever you use your microsoft account including apps on windows windows phone xbox and other devices you can do so by selecting the microsoft account option above ext legal privacy  cookies   microsoft investor faqs  ritter pharmaceuticals ritter pharmaceuticals  therapeutic treatments for gastrointestinal diseases careerscontact connect with us home about us history leadership overview leadership team medical advisory board board of directors lactose intolerance overview health consequences standard of care market opportunity patient resources microbiome modulation investors overview events  presentations corporate governance sec filings  stock info investor faqs contact us news press releases  news blog contact us contact us careers lactagen rpg product pipeline  print this page investor faqs when was ritter pharmaceuticals inc foundedritter pharmaceuticals inc was founded in where is ritter pharmaceuticals inc incorporatedritter pharmaceuticals inc is incorporated in the state of delawarewho are the members of ritter pharmaceuticals inc board of directorsyou can view our board of directors by visiting the board of directors section of our websitewho are the members of ritter pharmaceuticals inc management teamyou can view our management team by visiting the leadership page on our website when is ritter pharmaceuticals inc fiscal yearend december  who is ritter pharmaceuticals inc independent registered public accounting firmmayer hoffman  mccann pcon which exchange is ritter pharmaceuticals inc listed and what is the ticker symbolritter pharmaceuticals inc is traded on the nasdaq stock exchange under the symbol “rttr” view ritter pharmaceuticals on nasdaqcomwhen did ritter pharmaceuticals inc go publicritter pharmaceuticals inc went public on june   how can i purchase shares  shares can be purchased through a stockbroker of your choicedoes ritter pharmaceuticals inc have a direct stock purchase planritter pharmaceuticals inc does not offer a direct stock purchase plan does ritter pharmaceuticals inc pay dividends and have a dividend reinvestment programcurrently ritter pharmaceuticals inc does not offer a dividend or a dividend reinvestment program  what is ritter pharmaceuticals inc cusip number who is ritter pharmaceuticals inc transfer agent and how do i contact themcorporate stock transfer inchow can i replace my lost stock certificatesplease contact our transfer agent corporate stock transfer inc the company can look up your records and make any necessary adjustments there is a fee involved for replacing lost certificates  how can i get a copy of your annual report or any other sec filingsquarterly reports on form q annual reports on form k and sec filings are available under sec filings on the investor section of our corporate website additionally all sec filings can also be accessed directly from secgovwhere can i find recent ritter pharmaceuticals inc press releasesyou can view our recent press releases by visiting the news section of our websitewho can i contact if i am a member of the mediafor media inquiries please send an email to inforitterpharmacomwhere can i find more information on ritter pharmaceuticals inc rd programsyou can view information on our platform and programs by visiting the therapies and platform sections of our websitehow do i contact investor relations with a question or requestfor investor related questions please send an email to inforitterpharmacom investors contact us corporate governance events  presentations investor faqs overview sec filings  stock info home    about us    investors    therapies    platform    leadership    lactose intolerance    news     contact us    privacy policy    terms  conditions    site map  copyright  ritter pharmaceuticals all rights reserved featuring recent posts wordpress widget development by yd rttr  summary for ritter pharmaceuticals inc  yahoo financehomemailflickrtumblrnewssportsfinancecelebrityanswersgroupsmobilemoreyahoosearchsearchus markets open in  hr  minssp futures dow futures ritter pharmaceuticals inc rttrnasdaqcm  nasdaqcm delayed price currency in usdadd to watchlist at close pm edtpeople also watchctrvblphcatbopgneyegsummaryconversationsstatisticsprofilefinancialsoptionsholdershistorical dataanalystsddmmytdyymaxfull screenprevious closeopenbid x ask x days range   week range  volumeavg volumemarket capmbetanape ratio ttmeps ttmearnings dateaug    aug  dividend  yieldna naexdividend datenay target esttrade prices are not sourced from all marketsallnewspress releasesmarketwired• months agoritter pharmaceuticals reports first quarter  financial results and provides business updatesritter pharmaceuticals inc  a leading developer of novel therapeutic products that modulate the human gut microbiome to treat gastrointestinal diseases today reported financial results for the first sponsoredbanyan hillits easily the no  stock to ownpaul reveals his no  investment for   an investment that he says will hand you a rare onceinalifetime opportunity to become globenewswire• months agoritter pharmaceuticals announces issuance of new patents for its lactose intolerance treatment rpg and provides an update on its path forward into phase los angeles may   ritter pharmaceuticals inc a leading developer of novel therapeutic products that modulate the human gut microbiome to treat gastrointestinal diseases today announced that yahoo small businessdata disclaimerhelpsuggestionsprivacyabout our adsterms updated rttr key statistics  ritter pharmaceuticals inc financial ratios  marketwatch bulletin investor alert new york markets open in market snapshot analyst ratings expand keep open close expand keep open close expand keep open close expand keep open close expand keep open close ritter pharmaceuticals inc nasdaq rttr go set alerts find a broker join td ameritrade market index overview profile news charts financials historical quotes analyst estimates options sec filings insiders marketstatecountryus ritter pharmaceuticals inc after hours  quotes are delayed by  min jul    pm rttr quoteszigmancomposite   change   volume volume  quotes are delayed by  min quoteszigmancomposite previous close     change   day low day high    week low  week high   company description ritter pharmaceuticals inc engages in the development of novel therapeutic products which modulate the human gut microbiome to treat gastrointestinal diseases it focuses on the development and commercialization of rpg which is reduces the symptoms associated with lactose intolerance the comp ritter pharmaceuticals inc engages in the development of novel therapeutic products which modulate the human gut microbiome to treat gastrointestinal diseases it focuses on the development and commercialization of rpg which is reduces the symptoms associated with lactose intolerance the company was founded by ira e ritter and andrew j ritter on march   and is headquartered in los angeles ca valuation pe current  pe ratio with extraordinary items  price to book ratio  enterprise value to ebitda  efficiency income per employee  liquidity current ratio  quick ratio  cash ratio  profitability return on assets  return on equity  return on total capital  return on invested capital  capital structure officers and executives name age officer since title mr ira e ritter   executive chairman  chief strategic officer mr michael d step   chief executive officer  director mr andrew j ritter   president  director ms ellen f mochizuki   principal financial  accounting officer dr annkatrin petersenjappelli   chief medical officer insider actions – purchase – sale  – number of transactions  date name shares transaction value  matthew w foehr director    acquisition at  per share   michael d step ceo director    acquisition at  per share   michael d step ceo director    acquisition at  per share   michael d step ceo director    acquisition at  per share   matthew w foehr director    acquisition at  per share   michael d step ceo director    acquisition at  per share   stonehenge partners llc california    derivativenonderivative trans at  per share   stonehenge partners llc california    derivativenonderivative trans at  per share   stonehenge partners llc california    derivativenonderivative trans at  per share   gerald t proehl director    acquisition at  per share   matthew w foehr director    acquisition at  per share  newslatestcompanyusrttr marketwatch news on rttr almost half of auditor warnings about potential failure are on ipos  pm jan    francine mckenna newsnonmarketwatchcompanyusrttr other news on rttr neuroderm ndrm catches eye stock gains  in session  am july    zackscom zackscom featured highlights tcf financial bg foods ritter pharmaceuticals koppers holdings and caredx  am july    zackscom land on  winning stocks with the ignored rising pe trick  am july    zackscom q ritter pharmaceuticals inc  am may    edgar online  edg  q k premarket gainers as of  am  am april    seeking alpha what to watch in q upcoming healthcare data releases  am april    seeking alpha what investors need to know about ritters recent trial results  pm april    seeking alpha ritter pharmaceuticals rttr phase b topline trial results treatment of lactose intolerance  slideshow  pm march    seeking alpha ritter pharmas lactose intolerance candidate rpg shows positive effect in midstage study but only after excluding bad data shares down  premarket  am march    seeking alpha zacks bearish on ritter pharma shares slump   pm march    seeking alpha ritter pharmaceuticals the thesis has just changed dramatically  am march    seeking alpha avoid ritter pharmaceuticals  pm march    seeking alpha k ritter pharmaceuticals inc  am feb    edgar online  edg  q k set to explode ritter pharmaceuticals  pm feb    seeking alpha ritter pharmaceuticals registers secondary shares and it readies results  am jan    seeking alpha what to watch in q upcoming healthcare regulatory events and data releases  pm jan    seeking alpha todays analyst action  pm jan    seeking alpha biggest movers in manufacturing stocks now – fbio pbmd smi aezs  am dec    investorplacecom  pharmaceuticals stocks to buy now  am dec    investorplacecom ratings update  pm dec    seeking alpha loading more headlines at a glance ritter pharmaceuticals inc  century park east suite  los angeles california  phone   industry pharmaceuticals sector health carelife sciences fiscal yearend  view sec filings revenue na net income m employees  annual report for rttr newspressreleasecompanyusrttr press releases on rttr global lactose  food  beverage  pm july    pr newswire  prf technical insights on biotech stocks  idera pharma pieris pharma peregrine pharma and ritter pharma  am july    pr newswire  prf ritter pharmaceuticals reports first quarter  financial results and provides business updates  am may    marketwired ritter pharmaceuticals announces issuance of new patents for its lactose intolerance treatment rpg and provides an update on its path forward into phase   pm may    globenewswire ritter pharmaceuticals inc announces end of phase  meeting with the fda and initiates phase  program development activities  am april    marketwired ritter pharmaceuticals announces lactose intolerance treatment rpg demonstrated efficacy and clinically meaningful benefit in phase b clinical trial  pm march    marketwired ritter pharmaceuticals reports fourth quarter and full year  financial results and provides business update  am feb    marketwired ritter pharmaceuticals announces collaboration with university of british columbia to explore development of microbiome therapeutics in environmental enteropathy  am feb    marketwired ritter pharmaceuticals to ring todays nasdaq stock market closing bell to kickoff lactose intolerance awareness month  am jan    marketwired ritter pharmaceuticals inc nasdaq rttr to ring the nasdaq stock market closing bell  am jan    globenewswire microbiome therapeutics market by type fecal microbial transplant fmt drugs by application c difficile crohns disease inflammatory bowel disease ibd diabetes by region and segment forecasts     pm jan    pr newswire  prf ritter pharmaceuticals announces collaboration with university of nebraska to explore development of microbiome therapeutics in metabolic syndrome  am jan    marketwired ritter pharmaceuticals appoints william merino phd to its board of directors  am jan    marketwired ritter pharmaceuticals phase a lactose intolerance clinical trial microbiome data published in proceedings of the national academy of sciences  pm jan    marketwired ritter pharmaceuticals inc to present at the th annual ld micro main event on december    am nov    accesswire ritter pharmaceuticals reports third quarter  financial results and provides business update  am nov    marketwired ritter pharmaceuticals inc prices  public offering of common stock  am oct    marketwired ritter pharmaceuticals inc announces proposed public offering of common stock  pm oct    marketwired biotech stocks worth a glance testing sector trends  am oct    pr newswire  prf ritter pharmaceuticals concludes last patient visit of its phase b clinical trial of rpg for the treatment of lactose intolerance  am oct    marketwired loading more headlines trending tickers quoteszigmancomposite vuzi quoteszigmancomposite jcp quoteszigmancomposite nugt quoteszigmancomposite jnug quoteszigmancomposite tlt x powered by log in  am edt july   marketstatecountryus new york pre marketstatecountryuk london open marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest acorrected exxonmobil q factset eps consensus  cents revenue  bln akellyanne conway suggests hillary clinton’s language is more vulgar than anthony scaramucci’s aexxonmobil shares down  premarket aexxon mobil stock drops  premarket after q results aklatencor stock price target raised to  from  at b riley aintel stock price target raised to  from  at b riley aexxonmobil q revenue  bln vs  bln astarbucks shares sink but analysts are optimistic about future growth aexxonmobil q eps  cents vs  cents ameet the ‘hamilton’ actors who play up to  roles in the hit show aamazon stock price target raised to  from  at jp morgan aplantronics downgraded to neutral from overweight at jp morgan aqep resources stock price target cut to  from  at jp morgan aqep resources downgraded to neutral from overweight at jp morgan arenaissancere stock price target cut to  from  at jp morgan axl group stock price target raised to  from  at jp morgan aabbvie shares surge  on q profit revenue beats arenaissancere downgraded to neutral from overweight at jp morgan axl group upgraded to overweight from neutral at jp morgan astarbucks stock price target cut to  from  at jp morgan loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  ritter pharmaceuticals inc  rttr  stock price today  zacks quote overview stock activity open  day low  day high   wk low   wk high  avg volume  market cap  m dividend    beta  key earnings data earnings esp  most accurate est  current qtr est  current yr est  exp earnings date  prior year eps  exp eps growth yrna forward pe na peg ratio na medical » medical  drugs zacks earnings esp expected surprise prediction looks to find earnings surprises by focusing on the most recent analyst revisions this is done because generally speaking if an analyst reevaluates their earnings estimate right before an earnings release it means that they have fresh information which could potentially be more accurate than what analysts thought about a company two or three months ago the crux of this approach is comparing the most accurate estimate to the zacks consensus estimate although the zacks rank is also an important feature of the esp metric combining these two can help investors find stocks that are ready to beat the consensus at their next report and hopefully surge higher in price too in fact when combining a zacks rank  or better and a positive earnings esp stocks produced a positive surprise  of the time and best of all by using these parameters investors have seen  annual returns on average according to our  year backtest visit the earnings esp center see the full list of stocks to beat earnings research report for rttr all zacks’ analyst reports premium research for rttr zacks rank buy  zacks industry rank bottom  out of  zacks sector rank bottom   out of  style scores f value  f growth  f momentum  f vgm earnings esp  research report for rttr snapshot this is our short term rating system that serves as a timeliness indicator for stocks over the next  to  months how good is it see rankings and related performance below zacks rank definition annualized return  strong buy   buy   hold   sell   strong sell  sp   zacks rank education  learn more about the zacks rank zacks rank home  all zacks rank resources in one place zacks premium  the only way to get access to the zacks rank the style scores are a complementary set of indicators to use alongside the zacks rank it allows the user to better focus on the stocks that are the best fit for his or her personal trading style the scores are based on the trading styles of value growth and momentum theres also a vgm score v for value g for growth and m for momentum which combines the weighted average of the individual style scores into one score value score a growth score a momentum score a vgm score a within each score stocks are graded into five groups a b c d and f as you might remember from your school days an a is better than a b a b is better than a c a c is better than a d and a d is better than an f as an investor you want to buy stocks with the highest probability of success that means you want to buy stocks with a zacks rank  or  strong buy or buy which also has a score of an a or a b in your personal trading style zacks style scores education  learn more about the zacks style scores the zacks industry rank assigns a rating to each of the  x expanded industries based on their average zacks rank an industry with a larger percentage of zacks rank s and s will have a better average zacks rank than one with a larger percentage of zacks rank s and s the industry with the best average zacks rank would be considered the top industry  out of  which would place it in the top  of zacks ranked industries the industry with the worst average zacks rank  out of  would place in the bottom  zacks rank education  learn more about the zacks rank zacks industry rank education  learn more about the zacks industry rank the zacks sector rank assigns a rating to each of the  sectors based on their average zacks rank a sector with a larger percentage of zacks rank s and s will have a better average zacks rank than one with a larger percentage of zacks rank s and s zacks sector rank education  learn more about the zacks sector rank the sector with the best average zacks rank would be considered the top sector  out of  which would place it in the top  of zacks ranked sectors the sector with the worst average zacks rank  out of  would place in the bottom  zacks rank education  learn more about the zacks rank zacks sector rank education  learn more about the zacks sector rank the zacks equity research reports or zer for short are our inhouse independently produced research reports the ever popular onepage snapshot reports are generated for virtually every single zacks ranked stock its packed with all of the companys key stats and salient decision making information including the zacks rank zacks industry rank style scores the price consensus  surprise chart graphical estimate analysis and how a stocks stacks up to its peers the detailed multipage analyst report does an even deeper dive on the companys vital statistics in addition to all of the proprietary analysis in the snapshot the report also visually displays the four components of the zacks rank agreement magnitude upside and surprise provides a comprehensive overview of the company business drivers complete with earnings and sales charts a recap of their last earnings report and a bulleted list of reasons to buy or sell the stock it also includes an industry comparison table to see how your stock compares to its expanded industry and the sp  researching stocks has never been so easy or insightful as with the zer analyst and snapshot reports learn more about zacks equity research reports see more zacks equity research reports zacks earnings esp expected surprise prediction looks to find companies that have recently seen positive earnings estimate revision activity the idea is that more recent information is generally speaking more accurate and can be a better predictor of the future which can give investors an advantage in earnings season the technique has proven to be very useful for finding positive surprises in fact when combining a zacks rank  or better and a positive earnings esp stocks produced a positive surprise  of the time while they also saw  annual returns on average according to our  year backtest visit the earnings esp center see the full list of stocks to beat earnings this is our short term rating system that serves as a timeliness indicator for stocks over the next  to  months how good is it see rankings and related performance below zacks rank definition annualized return  strong buy   buy   hold   sell   strong sell  sp   zacks rank education  learn more about the zacks rank zacks rank home  all zacks rank resources in one place zacks premium  the only way to fully access the zacks rank the zacks industry rank assigns a rating to each of the  x expanded industries based on their average zacks rank an industry with a larger percentage of zacks rank s and s will have a better average zacks rank than one with a larger percentage of zacks rank s and s the industry with the best average zacks rank would be considered the top industry  out of  which would place it in the top  of zacks ranked industries the industry with the worst average zacks rank  out of  would place in the bottom  zacks rank education  learn more about the zacks rank zacks industry rank education  learn more about the zacks industry rank the zacks sector rank assigns a rating to each of the  sectors based on their average zacks rank a sector with a larger percentage of zacks rank s and s will have a better average zacks rank than one with a larger percentage of zacks rank s and s zacks sector rank education  learn more about the zacks sector rank the sector with the best average zacks rank would be considered the top sector  out of  which would place it in the top  of zacks ranked sectors the sector with the worst average zacks rank  out of  would place in the bottom  zacks rank education  learn more about the zacks rank zacks sector rank education  learn more about the zacks sector rank the style scores are a complementary set of indicators to use alongside the zacks rank it allows the user to better focus on the stocks that are the best fit for his or her personal trading style the three scores are based on the trading styles of growth value and momentum growth score a value score a momentum score a within each score stocks are graded into five groups a b c d and f as you might remember from your school days an a is better than a b a b is better than a c a c is better than a d and a d is better than an f as an investor you want to buy stocks with the highest probability of success that means you want to buy stocks with a zacks rank  or  strong buy or buy which also has a score of an a or a b zacks style scores education  learn more about the zacks style scores the style scores are a complementary set of indicators to use alongside the zacks rank it allows the user to better focus on the stocks that are the best fit for his or her personal trading style the scores are based on the trading styles of value growth and momentum theres also a vgm score v for value g for growth and m for momentum which combines the weighted average of the individual style scores into one score value score a growth score a momentum score a vgm score a within each score stocks are graded into five groups a b c d and f as you might remember from your school days an a is better than a b a b is better than a c a c is better than a d and a d is better than an f as an investor you want to buy stocks with the highest probability of success that means you want to buy stocks with a zacks rank  or  strong buy or buy which also has a score of an a or a b in your personal trading style zacks style scores education  learn more about the zacks style scores the zacks equity research reports or zer for short are our inhouse independently produced research reports the ever popular onepage snapshot reports are generated for virtually every single zacks ranked stock its packed with all of the companys key stats and salient decision making information including the zacks rank zacks industry rank style scores the price consensus  surprise chart graphical estimate analysis and how a stocks stacks up to its peers the detailed multipage analyst report does an even deeper dive on the companys vital statistics in addition to all of the proprietary analysis in the snapshot the report also visually displays the four components of the zacks rank agreement magnitude upside and surprise provides a comprehensive overview of the company business drivers complete with earnings and sales charts a recap of their last earnings report and a bulleted list of reasons to buy or sell the stock it also includes an industry comparison table to see how your stock compares to its expanded industry and the sp  researching stocks has never been so easy or insightful as with the zer analyst and snapshot reports learn more about zacks equity research reports see more zacks equity research reports   change in last  days view all zacks rank  strong buys premium research industry analysis top peers symbol zacks rank ritter pharmaceuticals inc rttr consort medical plc sponsored adr csrmy summit therapeutics plc smmt advanced accelerator applications sa aaap aerie pharmaceuticals inc aeri alcobra ltd adhd clinigen gp plc cligf see all medical  drugs peers zacks news for rttr neuroderm ndrm catches eye stock gains  in session am est zacks land on  winning stocks with the ignored rising pe trick am est zacks rttr what are zacks experts saying now zacks private portfolio services company summary ritter pharmaceuticals inc is involved in developing therapeutic products to treat inflammatory gastrointestinal and metabolic diseases its lead product candidate is rpg a novel microbiome modulator which is under development for the reduction of symptoms associated with lactose intolerance ritter pharmaceuticals inc is headquartered in los angeles california ritter pharmaceuticals inc  ipo candy skip to primary navigation skip to content becomeamember ipo candyeveryones favorite site for ipo insights and analysismain navigationhome » ritter pharmaceuticals incritter pharmaceuticals inc  by ritter pharmaceuticals inc develops therapeutic products for treatment of inflammatory gastrointestinal and metabolic diseases its product candidate is rpg a novel microbiome modulator which is under development for the reduction of symptoms associated with lactose intolerance rpg is designed to stimulate the growth of lactosemetabolizing bacteria in the colon thereby adapting the gut microbiome to assist in digesting the lactose that reaches the large intestine rpg has been studied in a phase a clinical trial the company was formerly known as ritter natural sciences llc and changed its name to ritter pharmaceuticals inc in september  ritter pharmaceuticals inc was founded in  and is headquartered in los angeles california ritter pharmaceuticals inc ritter pharmaceuticals inc develops therapeutic products for treatment of inflammatory gastrointestinal and metabolic diseases its product candidate is rpg a novel microbiome modulator which is under development for the reduction of symptoms associated with lactose intolerance rpg is designed to stimulate the growth of lactosemetabolizing bacteria in the colon thereby adapting the gut microbiome to assist in digesting the lactose that reaches the large intestine rpg has been studied in a phase a clinical trial the company was formerly known as ritter natural sciences llc and changed its name to ritter pharmaceuticals inc in september  ritter pharmaceuticals inc was founded in  and is headquartered in los angeles california twitter facebook google linkedin ritter pharmaceuticals incpritter pharmaceuticals inc develops therapeutic products for treatment of inflammatory gastrointestinal and metabolic diseases its product candidate is rpg a novel microbiome modulator which is under development for the reduction of symptoms associated with lactose intolerance rpg is designed to stimulate the growth of lactosemetabolizing bacteria in the colon thereby adapting the gut microbiome to assist in digesting the lactose that reaches the large intestine rpg has been studied in a phase a clinical trial the company was formerly known as ritter natural sciences llc and changed its name to ritter pharmaceuticals inc in september  ritter pharmaceuticals inc was founded in  and is headquartered in los angeles californiap caunited statesphone  rttr microbiomebased drug development documents roadshow main categoryhealthcare categoriesdrugs contact httpwwwritterpharmaceuticalscom  address century park east suite  los angeles california  united states we love ipos the ipo market provides a magical window into the most exciting technologies emerging consumer trends and important business developments  all testing their mettle in the crucible of the public markets we are constantly learning and researching to deliver the best insights available we are independent we have no vested interests driving our work all the investment banks and brokers on a deal are paid to do a sales and marketing job our job is to remain objective and use a factbased approach to evaluate the potential for an ipo we get the best ratings ipo candy has been recognized since  as the single best place to get commentary analysis and assets in the ipo market the most common writein comment we get from users is that they love what we do we share everything we know with three decades of research under our belt we want to share what we have learned and the best practices we have discovered our ipo university contains texts videos and resources to share our process and help everyone develop their skills become an ipocandy member enjoy the benefits of full access to our content including access to ipo roadshow slideshows and transcripts included in our posts members also get additional insights via email receive our monthly candygram and have access to our ipo calendar become a member ritter pharmaceuticals inc  rttr  stock price today  zacks rttr is up  today but wheres it headed in august privacy policy no cost no obligation to buy anything ever join sign in member sign in keep me signed in what does remember me do forgot password create a new account you are being directed to zackstrade a division of lbmz securities and licensed brokerdealer zackstrade and zackscom are separate companies the web link between the two companies is not a solicitation or offer to invest in a particular security or type of security zackstrade does not endorse or adopt any particular investment strategy any analyst opinionratingreport or any approach to evaluating indiv idual securities if you wish to go to zackstrade click ok if you do not click cancel ok cancel back to top more ritter pharmaceuticals inc rttr delayed data from nsdq  usd     updated jul    pm et add to portfolio zacks rank buy          style scores f value  f growth  f momentum  f vgm the style scores are a complementary set of indicators to use alongside the zacks rank it allows the user to better focus on the stocks that are the best fit for his or her personal trading style the scores are based on the trading styles of value growth and momentum theres also a vgm score v for value g for growth and m for momentum which combines the weighted average of the individual style scores into one score value score a growth score a momentum score a vgm score a within each score stocks are graded into five groups a b c d and f as you might remember from your school days an a is better than a b a b is better than a c a c is better than a d and a d is better than an f as an investor you want to buy stocks with the highest probability of success that means you want to buy stocks with a zacks rank  or  strong buy or buy which also has a score of an a or a b in your personal trading style zacks style scores education  learn more about the zacks style scores industry rank bottom  out of  industry medical  drugs view all zacks  ranked stocks trades from  this is our short term rating system that serves as a timeliness indicator for stocks over the next  to  months how good is it see rankings and related performance below zacks rank definition annualized return  strong buy   buy   hold   sell   strong sell  sp   zacks rank education  learn about the zacks rank zacks rank home  zacks rank resources in one place zacks premium  the only way to fully access the zacks rank the zacks equity research reports or zer for short are our inhouse independently produced research reports the ever popular onepage snapshot reports are generated for virtually every single zacks ranked stock its packed with all of the companys key stats and salient decision making information including the zacks rank zacks industry rank style scores the price consensus  surprise chart graphical estimate analysis and how a stocks stacks up to its peers the detailed multipage analyst report does an even deeper dive on the companys vital statistics in addition to all of the proprietary analysis in the snapshot the report also visually displays the four components of the zacks rank agreement magnitude upside and surprise provides a comprehensive overview of the company business drivers complete with earnings and sales charts a recap of their last earnings report and a bulleted list of reasons to buy or sell the stock it also includes an industry comparison table to see how your stock compares to its expanded industry and the sp  researching stocks has never been so easy or insightful as with the zer analyst and snapshot reports learn more about zacks equity research reports see more zacks equity research reports the zacks industry rank assigns a rating to each of the  x expanded industries based on their average zacks rank an industry with a larger percentage of zacks rank s and s will have a better average zacks rank than one with a larger percentage of zacks rank s and s the industry with the best average zacks rank would be considered the top industry  out of  which would place it in the top  of zacks ranked industries the industry with the worst average zacks rank  out of  would place in the bottom  zacks rank education  learn more about the zacks rank zacks industry rank education  learn more about the zacks industry rank quote overview stock activity open  day low  day high   wk low   wk high  avg volume  market cap  m dividend    beta  key earnings data earnings esp  most accurate est  current qtr est  current yr est  exp earnings date  prior year eps  exp eps growth yrna forward pe na peg ratio na medical » medical  drugs zacks earnings esp expected surprise prediction looks to find companies that have recently seen positive earnings estimate revision activity the idea is that more recent information is generally speaking more accurate and can be a better predictor of the future which can give investors an advantage in earnings season the technique has proven to be very useful for finding positive surprises in fact when combining a zacks rank  or better and a positive earnings esp stocks produced a positive surprise  of the time while they also saw  annual returns on average according to our  year backtest visit the earnings esp center see the full list of stocks to beat earnings research report for rttr all zacks’ analyst reports news for rttr zacks news for rttr other news for rttr neuroderm ndrm catches eye stock gains  in session am est zacks land on  winning stocks with the ignored rising pe trick am est zacks rttr what are zacks experts saying now zacks private portfolio services more zacks news for rttr ritter pharmaceuticals beats by  am est seeking alpha ritter pharmaceuticals announces issuance of new patents for its lactose intolerance treatment  am est gurufocus midday gainers  losers pm est seeking alpha healthcare  top  gainers  losers as of  am am est seeking alpha healthcare  top  gainers  losers as of  am am est seeking alpha more other news for rttr premium research for rttr zacks rank buy  zacks industry rank bottom  out of  zacks sector rank bottom   out of  style scores f value  f growth  f momentum  f vgm earnings esp  research report for rttr snapshot this is our short term rating system that serves as a timeliness indicator for stocks over the next  to  months how good is it see rankings and related performance below zacks rank definition annualized return  strong buy   buy   hold   sell   strong sell  sp   zacks rank education  learn more about the zacks rank zacks rank home  all zacks rank resources in one place zacks premium  the only way to get access to the zacks rank the style scores are a complementary set of indicators to use alongside the zacks rank it allows the user to better focus on the stocks that are the best fit for his or her personal trading style the scores are based on the trading styles of value growth and momentum theres also a vgm score v for value g for growth and m for momentum which combines the weighted average of the individual style scores into one score value score a growth score a momentum score a vgm score a within each score stocks are graded into five groups a b c d and f as you might remember from your school days an a is better than a b a b is better than a c a c is better than a d and a d is better than an f as an investor you want to buy stocks with the highest probability of success that means you want to buy stocks with a zacks rank  or  strong buy or buy which also has a score of an a or a b in your personal trading style zacks style scores education  learn more about the zacks style scores the zacks industry rank assigns a rating to each of the  x expanded industries based on their average zacks rank an industry with a larger percentage of zacks rank s and s will have a better average zacks rank than one with a larger percentage of zacks rank s and s the industry with the best average zacks rank would be considered the top industry  out of  which would place it in the top  of zacks ranked industries the industry with the worst average zacks rank  out of  would place in the bottom  zacks rank education  learn more about the zacks rank zacks industry rank education  learn more about the zacks industry rank the zacks sector rank assigns a rating to each of the  sectors based on their average zacks rank a sector with a larger percentage of zacks rank s and s will have a better average zacks rank than one with a larger percentage of zacks rank s and s zacks sector rank education  learn more about the zacks sector rank the sector with the best average zacks rank would be considered the top sector  out of  which would place it in the top  of zacks ranked sectors the sector with the worst average zacks rank  out of  would place in the bottom  zacks rank education  learn more about the zacks rank zacks sector rank education  learn more about the zacks sector rank the zacks equity research reports or zer for short are our inhouse independently produced research reports the ever popular onepage snapshot reports are generated for virtually every single zacks ranked stock its packed with all of the companys key stats and salient decision making information including the zacks rank zacks industry rank style scores the price consensus  surprise chart graphical estimate analysis and how a stocks stacks up to its peers the detailed multipage analyst report does an even deeper dive on the companys vital statistics in addition to all of the proprietary analysis in the snapshot the report also visually displays the four components of the zacks rank agreement magnitude upside and surprise provides a comprehensive overview of the company business drivers complete with earnings and sales charts a recap of their last earnings report and a bulleted list of reasons to buy or sell the stock it also includes an industry comparison table to see how your stock compares to its expanded industry and the sp  researching stocks has never been so easy or insightful as with the zer analyst and snapshot reports learn more about zacks equity research reports see more zacks equity research reports zacks earnings esp expected surprise prediction looks to find companies that have recently seen positive earnings estimate revision activity the idea is that more recent information is generally speaking more accurate and can be a better predictor of the future which can give investors an advantage in earnings season the technique has proven to be very useful for finding positive surprises in fact when combining a zacks rank  or better and a positive earnings esp stocks produced a positive surprise  of the time while they also saw  annual returns on average according to our  year backtest visit the earnings esp center see the full list of stocks to beat earnings this is our short term rating system that serves as a timeliness indicator for stocks over the next  to  months how good is it see rankings and related performance below zacks rank definition annualized return  strong buy   buy   hold   sell   strong sell  sp   zacks rank education  learn more about the zacks rank zacks rank home  all zacks rank resources in one place zacks premium  the only way to fully access the zacks rank the zacks industry rank assigns a rating to each of the  x expanded industries based on their average zacks rank an industry with a larger percentage of zacks rank s and s will have a better average zacks rank than one with a larger percentage of zacks rank s and s the industry with the best average zacks rank would be considered the top industry  out of  which would place it in the top  of zacks ranked industries the industry with the worst average zacks rank  out of  would place in the bottom  zacks rank education  learn more about the zacks rank zacks industry rank education  learn more about the zacks industry rank the zacks sector rank assigns a rating to each of the  sectors based on their average zacks rank a sector with a larger percentage of zacks rank s and s will have a better average zacks rank than one with a larger percentage of zacks rank s and s zacks sector rank education  learn more about the zacks sector rank the sector with the best average zacks rank would be considered the top sector  out of  which would place it in the top  of zacks ranked sectors the sector with the worst average zacks rank  out of  would place in the bottom  zacks rank education  learn more about the zacks rank zacks sector rank education  learn more about the zacks sector rank the style scores are a complementary set of indicators to use alongside the zacks rank it allows the user to better focus on the stocks that are the best fit for his or her personal trading style the three scores are based on the trading styles of growth value and momentum growth score a value score a momentum score a within each score stocks are graded into five groups a b c d and f as you might remember from your school days an a is better than a b a b is better than a c a c is better than a d and a d is better than an f as an investor you want to buy stocks with the highest probability of success that means you want to buy stocks with a zacks rank  or  strong buy or buy which also has a score of an a or a b zacks style scores education  learn more about the zacks style scores the style scores are a complementary set of indicators to use alongside the zacks rank it allows the user to better focus on the stocks that are the best fit for his or her personal trading style the scores are based on the trading styles of value growth and momentum theres also a vgm score v for value g for growth and m for momentum which combines the weighted average of the individual style scores into one score value score a growth score a momentum score a vgm score a within each score stocks are graded into five groups a b c d and f as you might remember from your school days an a is better than a b a b is better than a c a c is better than a d and a d is better than an f as an investor you want to buy stocks with the highest probability of success that means you want to buy stocks with a zacks rank  or  strong buy or buy which also has a score of an a or a b in your personal trading style zacks style scores education  learn more about the zacks style scores the zacks equity research reports or zer for short are our inhouse independently produced research reports the ever popular onepage snapshot reports are generated for virtually every single zacks ranked stock its packed with all of the companys key stats and salient decision making information including the zacks rank zacks industry rank style scores the price consensus  surprise chart graphical estimate analysis and how a stocks stacks up to its peers the detailed multipage analyst report does an even deeper dive on the companys vital statistics in addition to all of the proprietary analysis in the snapshot the report also visually displays the four components of the zacks rank agreement magnitude upside and surprise provides a comprehensive overview of the company business drivers complete with earnings and sales charts a recap of their last earnings report and a bulleted list of reasons to buy or sell the stock it also includes an industry comparison table to see how your stock compares to its expanded industry and the sp  researching stocks has never been so easy or insightful as with the zer analyst and snapshot reports learn more about zacks equity research reports see more zacks equity research reports   change in last  days view all zacks rank  strong buys premium research industry analysis top peers symbol zacks rank ritter pharmaceuticals inc rttr consort medical plc sponsored adr csrmy summit therapeutics plc smmt advanced accelerator applications sa aaap aerie pharmaceuticals inc aeri alcobra ltd adhd clinigen gp plc cligf see all medical  drugs peers price and eps surprise chart  month  months ytd interactive chart  fundamental chart billion dollar secret company summary ritter pharmaceuticals inc is involved in developing therapeutic products to treat inflammatory gastrointestinal and metabolic diseases its lead product candidate is rpg a novel microbiome modulator which is under development for the reduction of symptoms associated with lactose intolerance ritter pharmaceuticals inc is headquartered in los angeles california